{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:18:40Z","timestamp":1778728720106,"version":"3.51.4"},"reference-count":37,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.3892\/mmr.2014.2736","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T07:00:16Z","timestamp":1413961216000},"page":"712-718","source":"Crossref","is-referenced-by-count":22,"title":["Reactive oxygen species-mediated activation of the Src-epidermal growth factor receptor-Akt signaling cascade prevents bortezomib-induced apoptosis in hepatocellular carcinoma cells"],"prefix":"10.3892","volume":"11","author":[{"given":"JINLIN","family":"HOU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANGUO","family":"CUI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PEIYING","family":"SONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUI","family":"HUA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TING","family":"LUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YANGFU","family":"JIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,10,22]]},"reference":[{"key":"key20180108001741_b1-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/jsbi.1998.3958","article-title":"26S proteasome structure revealed by three-dimensional electron microscopy","volume":"121","author":"Walz","year":"1998","journal-title":"J Struct Biol"},{"key":"key20180108001741_b2-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbagrm.2010.08.008","article-title":"Structure characterization of the 26S proteasome","volume":"1809","author":"Kim","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key20180108001741_b3-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbamcr.2004.09.019","article-title":"Ubiquitin: structures, functions, mechanisms","volume":"1695","author":"Pickart","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"key20180108001741_b4-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.biocel.2007.05.004","article-title":"Nuclear factor-\u03baB1: regulation and function","volume":"40","author":"Pereira","year":"2008","journal-title":"Int J Biochem Cell Bio"},{"key":"key20180108001741_b5-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/emboj\/cdg158","article-title":"Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J"},{"key":"key20180108001741_b6-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cdd.2009.67","article-title":"Ubiquitin-independent p53 proteasomal degradation","volume":"17","author":"Tsvetkov","year":"2010","journal-title":"Cell Death Differ"},{"key":"key20180108001741_b7-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/jpet.105.096719","article-title":"Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen","volume":"317","author":"Lee","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"key20180108001741_b8-mmr-11-01-0712","first-page":"153","article-title":"Ubiquitin-independent degradation of proteins by the proteasome","volume":"1786","author":"Jariel-Encontre","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"key20180108001741_b9-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1158\/0008-5472.CAN-03-2707","article-title":"Bortezomib as a potential treatment for prostate cancer","volume":"64","author":"Papandreou","year":"2004","journal-title":"Cancer Res"},{"key":"key20180108001741_b10-mmr-11-01-0712","first-page":"596","article-title":"Bortezomib: a novel therapy approved for multiple myeloma","volume":"1","author":"Richardson","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"key20180108001741_b11-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3816\/CLM.2005.n.046","article-title":"Marked clinical activity of the proteasome inhibitor bortezomib in patients with follicular and mantle-cell lymphoma","volume":"6","author":"O\u2019Connor","year":"2005","journal-title":"Clin Lymphoma Myeloma"},{"key":"key20180108001741_b12-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.lfs.2009.12.003","article-title":"Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B","volume":"86","author":"Ko","year":"2010","journal-title":"Life Sci"},{"key":"key20180108001741_b13-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.seminoncol.2003.12.013","article-title":"Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy","volume":"31","author":"Lara","year":"2004","journal-title":"Semin Oncol"},{"key":"key20180108001741_b14-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1158\/0008-5472.CAN-08-0257","article-title":"Downregulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells","volume":"68","author":"Chen","year":"2008","journal-title":"Cancer Res"},{"key":"key20180108001741_b15-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.oraloncology.2012.01.012","article-title":"CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells","volume":"48","author":"Lin","year":"2012","journal-title":"Oral Oncol"},{"key":"key20180108001741_b16-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.advenzreg.2006.01.004","article-title":"Roles of the RAF\/MEK\/ERK and PI3K\/PTEN\/AKT pathways in malignant transformation and drug resistance","volume":"46","author":"McCubrey","year":"2006","journal-title":"Adv Enzyme Regul"},{"key":"key20180108001741_b17-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1074\/jbc.M210828200","article-title":"Src kinase mediates phosphatidylinositol 3-kinase\/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen","volume":"278","author":"Haynes","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180108001741_b18-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/sj.onc.1201496","article-title":"Activation of c-Src by receptor tyrosine kinases in human colon cancer cells with high metastatic potential","volume":"15","author":"Mao","year":"1997","journal-title":"Oncogene"},{"key":"key20180108001741_b19-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4161\/cbt.19239","article-title":"Bortezomib induces apoptosis and growth suppression in human medulloblastoma cells, associated with inhibition of AKT and NF-\u03baB signaling and synergizes with an ERK inhibitor","volume":"13","author":"Yang","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"key20180108001741_b20-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/cncr.21108","article-title":"A phase II study of bortezomib in the treatment of metastatic malignant melanoma","volume":"103","author":"Markovic","year":"2005","journal-title":"Cancer"},{"key":"key20180108001741_b21-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180108001741_b22-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ccr.2005.08.008","article-title":"The Akt-mTOR tango and its relevance to cancer","volume":"8","author":"Hay","year":"2005","journal-title":"Cancer Cell"},{"key":"key20180108001741_b23-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cell.2007.04.044","article-title":"CIP2A inhibits PP2A in human malignancies","volume":"130","author":"Junttila","year":"2007","journal-title":"Cell"},{"key":"key20180108001741_b24-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1038\/onc.2010.357","article-title":"CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells","volume":"29","author":"Chen","year":"2010","journal-title":"Oncogene"},{"key":"key20180108001741_b25-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1158\/1535-7163.MCT-06-0255","article-title":"Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib","volume":"6","author":"An","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"key20180108001741_b26-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/0008-5472.CAN-06-2162","article-title":"Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermal growth factor receptor inhibitor-induced cell death in squamous cell cancer","volume":"67","author":"Lorch","year":"2007","journal-title":"Cancer Res"},{"key":"key20180108001741_b27-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/1535-7163.MCT-05-0147","article-title":"Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells","volume":"5","author":"Codony-Servat","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"key20180108001741_b28-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1158\/1078-0432.CCR-07-4506","article-title":"Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells","volume":"14","author":"Sloss","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180108001741_b29-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/jcp.21444","article-title":"Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells","volume":"216","author":"Cascone","year":"2008","journal-title":"J Cell Physiol"},{"key":"key20180108001741_b30-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"key20180108001741_b31-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jhep.2009.10.011","article-title":"Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation","volume":"52","author":"Chen","year":"2010","journal-title":"J Hepatol"},{"key":"key20180108001741_b32-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ctrv.2009.11.005","article-title":"SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer","volume":"36","author":"Saad","year":"2010","journal-title":"Cancer Treat Rev"},{"key":"key20180108001741_b33-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.tiv.2013.01.017","article-title":"Hepatocytes display a compensatory survival response against cadmium toxicity by a mechanism mediated by EGFR and Src","volume":"27","author":"Martinez Flores","year":"2013","journal-title":"Toxicol In Vitro"},{"key":"key20180108001741_b34-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.yexcr.2004.02.001","article-title":"The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib","volume":"295","author":"Yu","year":"2004","journal-title":"Exp Cell Res"},{"key":"key20180108001741_b35-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0891-5849(03)00471-4","article-title":"Apoptosis of lymphocytes induced by chromium (VI\/V) is through ROS-mediated activation of Src-family kinases and caspase-3","volume":"35","author":"Vasant","year":"2003","journal-title":"Free Radic Biol"},{"key":"key20180108001741_b36-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.lungcan.2010.06.005","article-title":"Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors","volume":"71","author":"Morgillo","year":"2011","journal-title":"Lung Cancer"},{"key":"key20180108001741_b37-mmr-11-01-0712","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.leukres.2012.02.010","article-title":"The dual PI3K and mTOR inhibitor NVP-BEZ235 exhibits anti-proliferative activity and overcomes bortezomib resistance in mantle cell lymphoma cells","volume":"36","author":"Kim","year":"2012","journal-title":"Leuk Res"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2736\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:55:00Z","timestamp":1515372900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,10,22]]},"published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.3892\/mmr.2014.2736"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2736","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,22]]}}}